AU
UK
CA
NZ
IND
US
Sangamo Therapeutics (NASDAQ:SGMO) announced that the U.S.Food and Drug Administrationhas accepted its request for a rollingBiologics License Applicationsubmission for isaralgagene civaparvovec, the company's investigational gene therapy for adults with Fabry disease. A rolling submission allows the FDA to review sections of the application as …
Eli Lilly and Co. (NYSE:LLY) briefly became the first healthcare company in the world to reach avaluationof USD 1 trln, a milestone that underscores the accelerating growth of the global metabolic health and weight-loss treatment market.
RTX Corp. (NYSE:RTX) has received a notable uplift with its Raytheon-Rafael Protection Systemsjoint venturesecuring a USD 1.25 bln contract to supply Israel with Tamir surface-to-air missiles. The comprehensive order includes missile kits and associated test equipment, underscoring continued global interest in the Tamir interceptor’s …
KB Home (NYSE:KBH) announced significant expansion activity across Florida and California. One of the company’s newest additions is a single-family home community in St. Cloud, Florida. This development emphasizes energy-efficient construction, access to well-regarded schools, and proximity to daily conveniences. The launch aligns with …
Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. announced that the U.S.Food and Drug Administrationhas granted approval for PADCEV (enfortumab vedotin-ejfv) in combination with Merck’s Keytruda (pembrolizumab) or Keytruda QLEX. The therapy is now cleared for perioperative use in adults with muscle-invasive bladder cancer (MIBC) …
Gilead Sciences (NASDAQ:GILD) has completed the acquisition of the TREX1 cancer program from Sprint Bioscience AB. The agreement includes an upfront payment of USD 14 million and future potential milestone payments that could reach as high as USD 400 million.
Sanford C. Bernstein has increased its price objective for ConocoPhillips (NYSE:COP) from USD 115.00 to USD 116.00 in a recent research report. The brokerage reiterated an “outperform” rating, indicating confidence in the company’s outlook within the energy sector. ConocoPhillips operates a diversified global portfolio …
UBS Group has reiterated its Buy rating on NVIDIA Corporation (NASDAQ:NVDA), according to a research note shared on Thursday. The brokerage also kept its target price at USD 235, reinforcing its recent assessment of the semiconductor and computing hardware company. The latest update comes …
Market Movers:On Thursday, the top gainers were Mobile-health Network Solutions (+83.13%), followed by Epsium Enterprise Limited. (+66.36%). On the contrary Brera Holdings PLC. (-63.73%), and mF International Limited (-39.06%) declined the most the same day.
Veeva Systems (NYSE:VEEV) reported a meaningful revenue increase for its fiscal third quarter ended October 31, 2025, supported by steady demand for its cloud-based solutions tailored to the life sciences sector. Totalrevenuerose 16%year-over-yearto USD 811.2 million, compared with USD 699.2 million in Q3 FY25. …
Please wait processing your request...